Common dietary compound may support cancer treatment

Date:

Share this article:

Del denne artikel:

A common nutrient found in vegetables may help the immune system respond more effectively to cancer treatment, early research suggests.

New findings highlighted by ScienceDaily, based on research from the University of Chicago Medical Center and published in Cell Reports Medicine, point to a surprising link between everyday nutrition and cancer treatment.

Most people think of food as fuel or a way to stay healthy. But scientists are increasingly discovering that certain nutrients may do far more, potentially influencing how the body responds to serious diseases.

New research suggests that a naturally occurring compound in vegetables could help the immune system fight cancer more effectively.

A hidden role

The compound, called zeaxanthin, has long been associated with eye health. However, researchers led by Jing Chen, PhD, found it may also enhance the body’s immune response against tumors.

Also read: A daily intake of multivitamins linked to changes in biological age

Their work shows that zeaxanthin strengthens CD8+ T cells, which are responsible for identifying and destroying cancer cells.

Boosting immunity

The study indicates that zeaxanthin improves how these immune cells detect threats and respond more forcefully. This leads to stronger internal signaling and a more effective attack on tumors.

In animal studies, tumor growth slowed when the nutrient was introduced. The effect became even stronger when paired with immunotherapy treatments.

What comes next

Because zeaxanthin is already widely available and considered safe, researchers believe it could be explored as a supportive addition to cancer care.

Also read: How to manage your weight in your 50s

However, the findings remain at an early stage. Most evidence comes from laboratory and animal studies, meaning human trials are still needed before any clinical use can be confirmed.

Also read: Study points to new ways of understanding Alzheimer’s disease

This article is made and published by Mie Hermansen, who may have used AI in the preparation.

Other articles

GLP-1 drugs like Ozempic may now be an option for a group of patients long left out

The 2026 American Diabetes Association guidance opens GLP-1 therapy to a new patient group.

Your gut bacteria may spread to the people around you more easily than anyone realized

A new Nature study finds gut microbes spread between people, sometimes across continents, faster than expected.

Low vitamin C may be quietly speeding up how fast your brain ages

A study of 2,044 older adults links lower plasma vitamin C to shrinking brain volume and weaker memory-network wiring.

Why rheumatoid arthritis attacks some joints and not others: The answer starts before birth

Oxford scientists say certain finger joints may be biologically primed for the disease before you are born.

GLP-1 drugs like Ozempic may now be an option for a group of patients long left out

The 2026 American Diabetes Association guidance opens GLP-1 therapy to a new patient group.

Your gut bacteria may spread to the people around you more easily than anyone realized

A new Nature study finds gut microbes spread between people, sometimes across continents, faster than expected.

Low vitamin C may be quietly speeding up how fast your brain ages

A study of 2,044 older adults links lower plasma vitamin C to shrinking brain volume and weaker memory-network wiring.